目的探讨介入性超声腔内给药加硬化治疗肝包虫病的应用价值。
Objective This report is intended to probe into the practical value of sclerotic treatment of.
目的从细胞和分子水平观察隔药饼灸对兔高脂血症(HLP)合并动脉粥样硬化(as)的作用机理。
Objective to observe the mechanism of herbal cake separated moxibustion to hyperlipemia (HLP) and atherosclerosis (AS) rabbits on cell and molecular level.
结论—这些研究结果表明多药抗药性相关蛋白-1和白三烯C4都有致动脉粥样硬化作用，因此两者都有可能成为抗动脉粥样硬化治疗的靶向物质。
Conclusions-: These findings indicate that MRP1 and LTC4 exert proatherosclerotic effects and that both MRP1 and LTC4 are potentially promising targets for atheroprotective therapy.
我们假设多药抗药性相关蛋白-1介导的白三烯C4内位-外位转运是致血管系统动脉粥样硬化的重要机制。
We hypothesize that inside-outside transport of leukotriene C4 (LTC4) via MRP1 is a substantial proatherogenic mechanism in the vasculature.
目的研究8例肝硬化患者静脉滴注奥美拉唑(ome)的药动学特性。
OBJECTIVE To study the pharmacokinetics of omeprazole (ome) in 8 patients with liver cirrhosis.
这种药并不能治愈多发性硬化症，但可能会减缓一些不利影响，减少疾病复发的次数。
This medicine will not cure MS, but it may slow some disabling effects and decrease the number of relapses of the disease.
方法：对高血脂饲料喂食的鹌鹑灌胃给药，观察对血脂和动脉粥样硬化斑块组织形态变化情况。
METHODS Animal models of high blood lipid of partridge caused by high lipid forage were used. RESULTS The lipids of model and camellia oil groups were significantly higher than those of control group.
一级预防使早期粥样硬化消退，特效降脂药也可使中、晚期粥样硬化患者明显受益。
Primary treatment makes early as regression. Cholesterol-lowering agents also decrease morbidity of acute events in advanced as.
一级预防使早期粥样硬化消退，特效降脂药也可使中、晚期粥样硬化患者明显受益。
Primary treatment makes early as regression. Cholesterol-lowering agents also decrease morbidity of acute events in advanced as.
应用推荐